Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122800565 | 12280056 | 5 | F | 20160715 | 20160418 | 20160729 | EXP | GB-ROCHE-1606338 | ROCHE | 0.00 | A | F | Y | 0.00000 | 20160729 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122800565 | 12280056 | 1 | PS | AVASTIN | BEVACIZUMAB | 1 | Unknown | U | 125085 | SOLUTION FOR INFUSION | |||||||||
| 122800565 | 12280056 | 2 | SS | XELODA | CAPECITABINE | 1 | Unknown | U | 20896 | TABLET | |||||||||
| 122800565 | 12280056 | 3 | SS | DOMPERIDONE | DOMPERIDONE | 1 | Unknown | U | 0 | ||||||||||
| 122800565 | 12280056 | 4 | C | PYRIDOXINE | PYRIDOXINE | 1 | 0 | ||||||||||||
| 122800565 | 12280056 | 5 | C | LAXIDO | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122800565 | 12280056 | 1 | Product used for unknown indication |
| 122800565 | 12280056 | 2 | Product used for unknown indication |
| 122800565 | 12280056 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122800565 | 12280056 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122800565 | 12280056 | Asthenia | |
| 122800565 | 12280056 | Constipation | |
| 122800565 | 12280056 | Dry skin | |
| 122800565 | 12280056 | Dysphonia | |
| 122800565 | 12280056 | Dyspnoea | |
| 122800565 | 12280056 | Erythema | |
| 122800565 | 12280056 | Fatigue | |
| 122800565 | 12280056 | Infection | |
| 122800565 | 12280056 | Joint swelling | |
| 122800565 | 12280056 | Laceration | |
| 122800565 | 12280056 | Laryngeal injury | |
| 122800565 | 12280056 | Malaise | |
| 122800565 | 12280056 | Nasopharyngitis | |
| 122800565 | 12280056 | Neoplasm progression | |
| 122800565 | 12280056 | Pain in extremity | |
| 122800565 | 12280056 | Palmar-plantar erythrodysaesthesia syndrome | |
| 122800565 | 12280056 | Pyrexia | |
| 122800565 | 12280056 | Unevaluable event | |
| 122800565 | 12280056 | Vocal cord disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |